Table 1.
Clinical factors | 24 |
---|---|
Age, median (range) | 65 (47–87) |
Sex (N%) | |
Female | 14 (58.3) |
Male | 10 (41.7) |
Race (N%) | |
Black | 6 (25.0) |
White | 18 (75.0) |
Tumor Grade (N%) | |
Well differentiated | 1 (4.2) |
Moderately differentiated | 16 (66.7) |
Poorly differentiated | 5 (20.8) |
Missing | 2 (8.3) |
Stage (N%) | |
IA-IIA | 6 (25.0) |
IIB | 18 (75.0) |
Last Follow-up, median (range) | 21 months (4–92 months) |